You are here

ivacaftor

Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis

Pharmaceutical Business Review

Fri, 05/31/19 - 09:46 am

Vertex Pharmaceuticals

cystic fibrosis

Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year

Xconomy

Wed, 10/19/11 - 10:39 am

cystic fibrosis